United States of America Continuous Glucose Monitoring Market 規模およびシェア分析 - 成長トレンドおよび予測 (2024 - 2031)
United States of America Continuous Glucose Monitoring Market is Segmented By Components (Sensors, Transmitters & Receivers, Integrated System, Others), By Demographic (Adults (18-65), Geriatrics (65+), Pediatrics/ Teenagers), By Indication (Type 1 Diabetes, Gestational Diabetes, Type 2 Diabetes, Others), By End-User (Hospitals, Home Care, Clinics, Nursing Homes, Others). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of United States of America Continuous Glucose Monitoring Market
米国で動作する主要なプレーヤー連続グルコース監視市場には、Abbott、Dexcom、Inc.、Medtronic、Senseonics、Inc.、F. Hoffmann-La Roche Ltd.、GLUCOVATION、Inc.、Nemaura Medical Inc.、GlySens、GlucoModicum、Signos、Inc.が含まれます。
United States of America Continuous Glucose Monitoring Market Leaders
- アボット
- 株式会社デックスコム
- メドトロニック
- 株式会社センスニクス
- F.ホフマン・ラ・ロチェ株式会社
*Disclaimer: Major players are listed in no particular order.
United States of America Continuous Glucose Monitoring Market - Competitive Rivalry, 2023
United States of America Continuous Glucose Monitoring Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights